Compare HCSG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | ORIC |
|---|---|---|
| Founded | 1976 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1994 | 2020 |
| Metric | HCSG | ORIC |
|---|---|---|
| Price | $18.50 | $12.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 13 |
| Target Price | $19.83 | ★ $20.00 |
| AVG Volume (30 Days) | 552.0K | ★ 1.2M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.83 | 19.67 |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $1,837,173,000.00 | N/A |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $5.22 | N/A |
| P/E Ratio | $23.59 | ★ N/A |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $9.13 | $3.90 |
| 52 Week High | $22.98 | $14.93 |
| Indicator | HCSG | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 36.52 | 52.17 |
| Support Level | $18.28 | $11.37 |
| Resistance Level | $19.77 | $12.60 |
| Average True Range (ATR) | 0.67 | 0.79 |
| MACD | -0.15 | -0.06 |
| Stochastic Oscillator | 1.79 | 66.74 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.